EHE Rare Cancer Foundation (Australia) Limited
About
Small charity, established 2015. Purposes: health. Serves: children, young people, older people, people with chronic illness. Operates in: VIC.
Giving Philosophy
The foundation's giving philosophy is patient-centred, driven by the belief that there is a critical lack of funding for EHE, a rare cancer. They aim to attract researchers and support initiatives to improve care, quality of life outcomes, and survival for EHE patients globally. They emphasize collaboration with sister charities in the United States and United Kingdom to create a global change movement.
Tips for Applicants
Prospective applicants should demonstrate a clear alignment with the foundation's mission to promote the prevention, control, and cure of Epithelioid Hemangioendothelioma (EHE). Proposals should highlight how they contribute to patient support, research, awareness, or advocacy for this rare vascular cancer. Emphasizing patient-centred outcomes, global collaboration, or addressing the lack of funding for EHE will be beneficial.
Financial History (7 years)
| Year | Revenue | Expenses | Assets | Surplus |
|---|---|---|---|---|
| 2023 | $19K | $18K | $151K | $679 |
| 2022 | $49K | $26K | $150K | $22K |
| 2021 | $33K | $44K | — | $-11,355 |
| 2020 | $22K | $2K | — | $21K |
| 2019 | $42K | $21K | $124K | $21K |
| 2018 | $34K | $35K | — | $-1,358 |
| 2017 | $44K | $5K | $98K | $39K |
Community Evidence
External EvidenceIdentity
- GS ID
- AU-ABN-91605700338
- ABN
- 91605700338
- Sector
- health
- Website
- www.ehefoundation.com.au
- Financial Year
- 2023
Focus Areas
Board & Leadership
- Jane Biddlecombe - Founding Director, Chair of the Board of Directors, Treasurer, Director of Fundraising and Sponsorship, Director of Consumer and Stakeholder Support
- Jonathan Granek - Founding Director, Deputy Chair of the Board of Directors
- Dr. David Speakman - Medical Oncologist, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Associate Director Cancer Trials Australia, Chair of the Clinical Oncology Society of Australia (COSA) Rare Cancer Group
- Dr. Brian Rubin MD, PhD - Professor and Vice Chair, Pathology, Cleveland Clinic, USA, Director, Soft Tissue Pathology, Cleveland Clinic, USA, Lead Investigator, International EHE Research Program
- Professor David Thomas - Director of The Kinghorn Cancer Centre and Head of the Cancer Theme of the Garvan Institute in NSW, CEO Australian Genomic Cancer Medicine Centre
Financials
- Revenue
- $19K
- Assets
- $151K
Method
- Match Confidence
- registry
- Cross-references
- 2 datasets
- Match Key
- ABN
- Relationships
- 8
Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.
Data Sources
Location Intelligence
- Postcode
- 0810
- Locality
- Nightcliff
- Remoteness
- Outer Regional Australia
- SEIFA Disadvantage
- Decile 7/10
- LGA
- Darwin
- SA2 Region
- Nightcliff
- Entities in Area
- 481